Clinical Trial Update: Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of LY451395 in patients with probable Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY451395

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED